Astellas Pharma | 4503 - Gross Profit On Sales


Astellas Pharma reported JPY444.26B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Astellas Pharma JPY 444.26B 12.55B Mar/2026
Chugai Pharma JPY 258.74B 25.81B Dec/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Eisai JPY 153.41B 15.44B Mar/2026
Kyowa Hakko Kirin JPY 88.25B 21.26B Mar/2026
M3 JPY 41.89B 6.08B Mar/2026
Otsuka Holdings JPY 456.25B 1.16B Mar/2026
Shionogi JPY 110.89B 11.74B Mar/2026
Sumitomo Dainippon JPY 54.28B 19.25B Mar/2026
Takeda JPY 688.84B 101.71B Mar/2026
Terumo JPY 149.02B 4.17B Mar/2026